NCT02338518 2023-09-29
SVOSA
Jinling Hospital, China
Phase 3 Unknown
Clinical Trials
10 trialsNCT03801668 2022-01-04
Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma
Huazhong University of Science and Technology
Phase 3 Unknown
NCT03961867 2021-06-01
Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric Adenocarcinoma
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3 Unknown
NCT04135781 2020-03-23
Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage â…¢ Gastric Cancer
Zhejiang Cancer Hospital
Phase 3 Unknown
NCT03475615 2018-03-23
A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant Ascites
Fudan University
Phase 3 Unknown
NCT03061058 2017-09-15
Individualized Intraperitoneal and System Chemotherapy Versus System Chemotherapy as First-line Chemotherapy for AGC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 3 Unknown
NCT01795027 2016-10-25
CAPITAL
Sun Yat-sen University
Phase 3 Unknown
NCT02677597 2016-02-09
Cisplatin Combined With S-1 or Paclitaxel as First-line Treatment for Metastatic Esophageal Squamous Cell Carcinoma
Fudan University
Phase 3 Unknown
NCT02319187 2015-08-03
Irinotecan Plus S1 Versus S1 in Patients With Previously Treated Advanced Esophageal Cancer: ESWN 01 Trial
ChineseAMS
Phase 3 Unknown
NCT01283217 2013-06-04
Docetaxel and S1 (DS) Versus S1 and Cisplatin (SP) in Curatively Resected Stage IIIB/IV Gastric Cancer
Yonsei University
Phase 3 Unknown